This highlights the importance of targeting Gal1 to reduce tumour growth as demonstrated by Gal1 knockdown in breast cancer cells, which significantly reduced tumour burden with a marked decrease in tumour growth [11]. The gene discussed is LGALS1; the disease is neoplasm.